Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells
摘要：
Curcumin (diferuloylmethane), a polyphenol natural product of the plant Curcuma longa , is undergoing early clinical trials as a novel anticancer agent. However, the anticancer mechanism of curcumin remains to be elucidated. Here we show that curcumin inhibited growth of rhabdomyosarcoma cells (Rh1 and Rh30) (IC50 = 2-5 M) and arrested cells in G1 phase of the cell cycle. Curcumin also induced apoptosis and inhibited the basal or type I insulin-like growth factor-induced motility of the cells. At physiological concentrations (2.5 M), curcumin rapidly inhibited phosphorylation of the mammalian target of rapamycin (mTOR) and its downstream effector molecules, p70 S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E (eIF4E) binding protein 1 (4E-BP1), in a panel of cell lines (Rh1, Rh30, DU145, MCF-7 and Hela). Curcumin also inhibited phosphorylation of Akt in the cells, but only at high concentrations (>40 M). The data suggest that curcumin may execute its anticancer activity primarily by blocking mTOR-mediated signaling pathways in the tumor cells. 2006 Wiley-Liss, Inc.
展开
DOI：
10.1002/ijc.21932
被引量：
年份：
2010
Wiley
(全网免费下载)
Wiley
Wiley
EBSCO
Wiley
查看更多
万方医学
Semantic Scholar
dx.doi.org
NCBI
Europe PMC
NCBI
NRC Research Press
ProQuest
EureKaMag.com
EureKaMag.com
(全网免费下载)
ResearchGate
(全网免费下载)
ResearchGate
theoncologist.alphamedpress.org
transplantation-proceedings.org
clinical-lung-cancer.com
cebp.aacrjournals.org
onAcademic
pherobase.com
molpharm.aspetjournals.org
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
研究点推荐
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
